Form 4: MariMed CEO Jon Levine Receives RSU Grant

MariMed Inc. President and CEO Jon Levine was granted 122,500 restricted stock units in lieu of a portion of his 2025 annual cash bonus.

Summary

• President and CEO Jon Levine received a grant of 122,500 Restricted Stock Units (RSUs) on April 15, 2026.
• The grant was issued in lieu of a cash payment for a portion of the executive's 2025 annual bonus.
• The RSUs convert to common stock on a one-for-one basis.
• Vesting is scheduled in four equal installments on July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation that does not signal a change in company strategy or financial health.

Positives

• Aligns executive compensation with long-term shareholder interests through equity-based incentives.
• Preserves corporate cash reserves by substituting equity for a portion of the annual cash bonus.

Negatives

• Results in minor dilution to existing shareholders upon the eventual vesting and conversion of the RSUs.

Risks

• Potential for future dilution if additional equity-based compensation is issued to management.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on executive compensation structure.

Management Comments

• The Reporting Person disclaims beneficial ownership of securities held in the Jon Levine Family Trust.

Industry Context

StockSavvy.ai notes that it is common practice in the cannabis sector for executives to accept equity in lieu of cash bonuses to conserve capital for operational expansion and regulatory compliance costs.

Comparison to Industry Standards

• The use of equity-based compensation to preserve cash is a standard practice among small-to-mid-cap cannabis companies.
• The vesting schedule of one year is consistent with standard executive retention programs in the industry.

Related Party Transactions

• Disclosure of 6,684,640 shares held by the Jon Levine Family Trust for the benefit of the Reporting Person's spouse and children.

Stakeholder Impact

• Shareholders may experience minor dilution upon the vesting of these units.

Next Steps

• Vesting of RSU installments beginning July 15, 2026.

Key Dates

Keywords

MariMed, MRMD, Insider Trading, Form 4, Executive Compensation, Restricted Stock Units, Jon Levine